Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

18F-Fluciclovine parameters on targeted prostate biopsy associated with true positivity in recurrent prostate cancer.

Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo OO, Tade FI, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Fei B, Schuster DM.

J Nucl Med. 2019 Apr 6. pii: jnumed.119.227033. doi: 10.2967/jnumed.119.227033. [Epub ahead of print]

PMID:
30954940
2.

Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.

Fei B, Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo O, Tade F, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Schuster DM.

J Urol. 2019 Feb 28:101097JU0000000000000200. doi: 10.1097/JU.0000000000000200. [Epub ahead of print]

PMID:
30817240
3.

Feasibility of Hyperfunctioning Parathyroid Gland Localization Using [18F]fluciclovine PET/CT.

Akintayo AA, Abiodun-Ojo OA, Weber C, Sharma J, Cohen C, Sica G, Halkar R, Goodman MM, Schuster DM.

Mol Imaging Biol. 2019 Jan 7. doi: 10.1007/s11307-018-01309-y. [Epub ahead of print]

PMID:
30617729
4.

Effect of age and autism spectrum disorder on oxytocin receptor density in the human basal forebrain and midbrain.

Freeman SM, Palumbo MC, Lawrence RH, Smith AL, Goodman MM, Bales KL.

Transl Psychiatry. 2018 Dec 4;8(1):257. doi: 10.1038/s41398-018-0315-3.

5.

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas.

Parent EE, Benayoun M, Ibeanu I, Olson JJ, Hadjipanayis CG, Brat DJ, Adhikarla V, Nye J, Schuster DM, Goodman MM.

EJNMMI Res. 2018 Jul 25;8(1):67. doi: 10.1186/s13550-018-0415-3.

6.

Selective modification of fluciclovine (18F) transport in prostate carcinoma xenografts.

Tade FI, Wiles WG 4th, Lu G, Bilir B, Akin-Akintayo O, Lee JS, Patil D, Yu W, Ormenisan Gherasim C, Fei B, Moreno CS, Osunkoya AO, Teoh EJ, Oka S, Okudaira H, Goodman MM, Schuster DM.

Amino Acids. 2018 Sep;50(9):1301-1305. doi: 10.1007/s00726-018-2600-0. Epub 2018 Jun 15.

PMID:
29905905
7.

Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.

Akin-Akintayo O, Tade F, Mittal P, Moreno C, Nieh PT, Rossi P, Patil D, Halkar R, Fei B, Master V, Jani AB, Kitajima H, Osunkoya AO, Ormenisan-Gherasim C, Goodman MM, Schuster DM.

Eur J Radiol. 2018 May;102:1-8. doi: 10.1016/j.ejrad.2018.02.006. Epub 2018 Feb 24.

8.

Novel PET and Near Infrared Imaging Probes for the Specific Detection of Bacterial Infections Associated With Cardiac Devices.

Takemiya K, Ning X, Seo W, Wang X, Mohammad R, Joseph G, Titterington JS, Kraft CS, Nye JA, Murthy N, Goodman MM, Taylor WR.

JACC Cardiovasc Imaging. 2019 May;12(5):875-886. doi: 10.1016/j.jcmg.2018.02.011. Epub 2018 Apr 18.

PMID:
29680350
9.

Factors Impacting the Performance Characteristics of Bile Duct Brushings: A Clinico-Cytopathologic Analysis of 253 Patients.

Hacihasanoglu E, Memis B, Pehlivanoglu B, Avadhani V, Freedman AA, Goodman MM, Adsay NV, Reid MD.

Arch Pathol Lab Med. 2018 Jul;142(7):863-870. doi: 10.5858/arpa.2017-0150-OA. Epub 2018 Mar 27.

PMID:
29582676
10.

Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HT2C Receptors.

Zeng F, Nye JA, Voll RJ, Howell L, Goodman MM.

ACS Med Chem Lett. 2018 Feb 5;9(3):188-192. doi: 10.1021/acsmedchemlett.7b00443. eCollection 2018 Mar 8.

11.

Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation.

Lipowska M, Jarkas N, Voll RJ, Nye JA, Klenc J, Goodman MM, Taylor AT.

Nucl Med Biol. 2018 Mar;58:42-50. doi: 10.1016/j.nucmedbio.2017.12.001. Epub 2017 Dec 27.

12.

Radiochemical Synthesis and Evaluation of 13N-Labeled 5-Aminolevulinic Acid for PET Imaging of Gliomas.

Pippin AB, Voll RJ, Li Y, Wu H, Mao H, Goodman MM.

ACS Med Chem Lett. 2017 Nov 15;8(12):1236-1240. doi: 10.1021/acsmedchemlett.7b00311. eCollection 2017 Dec 14.

13.

Synthesis and biological properties of radiohalogenated α,α-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs).

Goodman MM, Yu W, Jarkas N.

J Labelled Comp Radiopharm. 2018 Mar;61(3):272-290. doi: 10.1002/jlcr.3584. Epub 2018 Feb 6.

PMID:
29143354
14.

Test-Retest Reliability of the SERT Imaging Agent 11C-HOMADAM in Healthy Humans.

Adhikarla V, Dunlop BW, Jarkas N, Goodman MM, Mayberg H, Owens MJ, Nye JA.

J Nucl Med. 2018 Feb;59(2):315-319. doi: 10.2967/jnumed.117.196915. Epub 2017 Sep 21.

15.

Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.

Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB Jr, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, Pagni M, Liu L, Nykter M, Chen K, Hawkins GA, Grant SC, Petty WJ, Alistar AT, Levine EA, Staren ED, Langefeld CD, Miller V, Singal G, Petro RM, Robinson M, Blackstock W, Powell BL, Wagner LI, Foley KL, Abraham E, Pasche B, Zhang W.

Theranostics. 2017 Jul 12;7(11):2914-2923. doi: 10.7150/thno.20355. eCollection 2017.

16.

PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.

Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H.

Theranostics. 2017 May 15;7(7):2048-2064. doi: 10.7150/thno.19883. eCollection 2017.

17.

Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.

Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H.

Int J Mol Sci. 2017 Apr 29;18(5). pii: E934. doi: 10.3390/ijms18050934.

18.

An evaluation of central penetration from a peripherally administered oxytocin receptor selective antagonist in nonhuman primates.

Smith AL, Walum H, Connor-Stroud F, Freeman SM, Inoue K, Parr LA, Goodman MM, Young LJ.

Bioorg Med Chem. 2017 Jan 1;25(1):305-315. doi: 10.1016/j.bmc.2016.10.035. Epub 2016 Oct 31.

19.

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.

Akin-Akintayo OO, Jani AB, Odewole O, Tade FI, Nieh PT, Master VA, Bellamy LM, Halkar RK, Zhang C, Chen Z, Goodman MM, Schuster DM.

Clin Nucl Med. 2017 Jan;42(1):e22-e28.

20.

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.

Bach-Gansmo T, Nanni C, Nieh PT, Zanoni L, Bogsrud TV, Sletten H, Korsan KA, Kieboom J, Tade FI, Odewole O, Chau A, Ward P, Goodman MM, Fanti S, Schuster DM, Willoch F.

J Urol. 2017 Mar;197(3 Pt 1):676-683. doi: 10.1016/j.juro.2016.09.117. Epub 2016 Oct 13.

21.

In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats.

Pippin AB, Mohd Arshad ZH, Voll RJ, Nye JA, Ghassabian S, Williams CM, Mancini A, Liotta DC, Smith MT, Goodman MM.

ACS Med Chem Lett. 2016 Mar 30;7(6):563-7. doi: 10.1021/acsmedchemlett.5b00410. eCollection 2016 Jun 9.

22.

Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys.

Smith AL, Freeman SM, Barnhart TE, Abbott DH, Ahlers EO, Kukis DL, Bales KL, Goodman MM, Young LJ.

Bioorg Med Chem Lett. 2016 Jul 15;26(14):3370-3375. doi: 10.1016/j.bmcl.2016.04.097. Epub 2016 May 7.

23.

Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.

Adhikarla V, Zeng F, Votaw JR, Goodman MM, Nye JA.

Nucl Med Biol. 2016 May;43(5):318-23. doi: 10.1016/j.nucmedbio.2016.02.008. Epub 2016 Feb 28.

24.

Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Odewole OA, Tade FI, Nieh PT, Savir-Baruch B, Jani AB, Master VA, Rossi PJ, Halkar RK, Osunkoya AO, Akin-Akintayo O, Zhang C, Chen Z, Goodman MM, Schuster DM.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1773-83. doi: 10.1007/s00259-016-3383-8. Epub 2016 Apr 18.

25.

Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.

Tade FI, Cohen MA, Styblo TM, Odewole OA, Holbrook AI, Newell MS, Savir-Baruch B, Li X, Goodman MM, Nye JA, Schuster DM.

J Nucl Med. 2016 Sep;57(9):1357-63. doi: 10.2967/jnumed.115.171389. Epub 2016 Apr 7.

26.

Selective localization of oxytocin receptors and vasopressin 1a receptors in the human brainstem.

Freeman SM, Smith AL, Goodman MM, Bales KL.

Soc Neurosci. 2017 Apr;12(2):113-123. doi: 10.1080/17470919.2016.1156570. Epub 2016 Mar 10.

27.
28.

Preparation of 1-Tosyloxy-4-Substituted-2-butenes Using Ag(I) Salts.

Stehouwer JS, Goodman MM.

Tetrahedron Lett. 2015 Jul 22;56(30):4480-4482.

29.

[(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.

Ono M, Oka S, Okudaira H, Nakanishi T, Mizokami A, Kobayashi M, Schuster DM, Goodman MM, Shirakami Y, Kawai K.

Nucl Med Biol. 2015 Nov;42(11):887-92. doi: 10.1016/j.nucmedbio.2015.07.005. Epub 2015 Jul 15.

PMID:
26278491
30.

Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Stehouwer JS, Birnbaum MS, Voll RJ, Owens MJ, Plott SJ, Bourke CH, Wassef MA, Kilts CD, Goodman MM.

Bioorg Med Chem. 2015 Aug 1;23(15):4286-302. doi: 10.1016/j.bmc.2015.06.036. Epub 2015 Jun 19.

31.

Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.

Schuster DM, Nanni C, Fanti S, Oka S, Okudaira H, Inoue Y, Sörensen J, Owenius R, Choyke P, Turkbey B, Bogsrud TV, Bach-Gansmo T, Halkar RK, Nye JA, Odewole OA, Savir-Baruch B, Goodman MM.

J Nucl Med. 2014 Dec;55(12):1986-92. doi: 10.2967/jnumed.114.143628. Epub 2014 Nov 13.

32.

Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis.

Odewole OA, Oyenuga OA, Tade F, Savir-Baruch B, Nieh PT, Master V, Chen Z, Wang X, Jani AB, Bellamy LM, Halkar RK, Goodman MM, Schuster DM.

Mol Imaging Biol. 2015 Apr;17(2):277-83. doi: 10.1007/s11307-014-0797-1.

33.
34.

A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates.

Howell LL, Nye JA, Stehouwer JS, Voll RJ, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman MM, Carroll FI, Woods JH.

Transl Psychiatry. 2014 Jul 1;4:e407. doi: 10.1038/tp.2014.48.

35.

Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.

Okudaira H, Oka S, Ono M, Nakanishi T, Schuster DM, Kobayashi M, Goodman MM, Tamai I, Kawai K, Shirakami Y.

Mol Imaging Biol. 2014 Dec;16(6):756-64. doi: 10.1007/s11307-014-0756-x.

36.

The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta).

Freeman SM, Inoue K, Smith AL, Goodman MM, Young LJ.

Psychoneuroendocrinology. 2014 Jul;45:128-41. doi: 10.1016/j.psyneuen.2014.03.023. Epub 2014 Apr 12.

37.

Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus).

Freeman SM, Walum H, Inoue K, Smith AL, Goodman MM, Bales KL, Young LJ.

Neuroscience. 2014 Jul 25;273:12-23. doi: 10.1016/j.neuroscience.2014.04.055. Epub 2014 May 9.

38.

Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.

Nye JA, Votaw JR, Bremner JD, Davis MR, Voll RJ, Camp VM, Goodman MM.

Nucl Med Biol. 2014 Mar;41(3):217-22. doi: 10.1016/j.nucmedbio.2013.12.013. Epub 2013 Dec 26.

39.

Oestradiol alters central 5-HT1A receptor binding potential differences related to psychosocial stress but not differences related to 5-HTTLPR genotype in female rhesus monkeys.

Michopoulos V, Perez Diaz M, Embree M, Reding K, Votaw JR, Mun J, Voll RJ, Goodman MM, Wilson M, Sanchez M, Toufexis D.

J Neuroendocrinol. 2014 Feb;26(2):80-8. doi: 10.1111/jne.12129.

40.

An improved synthesis of [11C]MENET via Suzuki coupling with [11C]methyl iodide.

Zeng F, Voll RJ, Crowe RJ, Waldrep MS, Dolph KB, Goodman MM.

J Labelled Comp Radiopharm. 2013 May 15;56(5):307-9. doi: 10.1002/jlcr.3047. Epub 2013 Apr 24.

PMID:
24285377
41.

(11) C and (18) F PET radioligands for the serotonin transporter (SERT).

Stehouwer JS, Goodman MM.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):114-9. doi: 10.1002/jlcr.3011. Review.

PMID:
24285317
42.

Synthesis of a phenolic precursor and its efficient O-[18F]fluoroethylation with purified no-carrier-added [18F]2-fluoroethyl brosylate as the labeling agent.

Jarkas N, Voll RJ, Goodman MM.

J Labelled Comp Radiopharm. 2013 Sep;56(11):539-43. doi: 10.1002/jlcr.3046. Epub 2013 May 3.

PMID:
24285185
43.

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Schuster DM, Nieh PT, Jani AB, Amzat R, Bowman FD, Halkar RK, Master VA, Nye JA, Odewole OA, Osunkoya AO, Savir-Baruch B, Alaei-Taleghani P, Goodman MM.

J Urol. 2014 May;191(5):1446-53. doi: 10.1016/j.juro.2013.10.065. Epub 2013 Oct 19.

44.

Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.

Oka S, Okudaira H, Ono M, Schuster DM, Goodman MM, Kawai K, Shirakami Y.

Mol Imaging Biol. 2014 Jun;16(3):322-9. doi: 10.1007/s11307-013-0693-0.

PMID:
24136390
45.

Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.

Ono M, Oka S, Okudaira H, Schuster DM, Goodman MM, Kawai K, Shirakami Y.

Brain Res. 2013 Oct 16;1535:24-37. doi: 10.1016/j.brainres.2013.08.037. Epub 2013 Aug 27.

PMID:
23994214
46.

Investigation of an F-18 oxytocin receptor selective ligand via PET imaging.

Smith AL, Freeman SM, Voll RJ, Young LJ, Goodman MM.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5415-20. doi: 10.1016/j.bmcl.2013.07.045. Epub 2013 Jul 30.

47.

CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys.

Michopoulos V, Embree M, Reding K, Sanchez MM, Toufexis D, Votaw JR, Voll RJ, Goodman MM, Rivier J, Wilson ME, Berga SL.

Neuroscience. 2013 Oct 10;250:300-8. doi: 10.1016/j.neuroscience.2013.07.002. Epub 2013 Jul 12.

48.

Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH.

Neuropsychopharmacology. 2013 Oct;38(11):2179-87. doi: 10.1038/npp.2013.115. Epub 2013 May 9.

49.

Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.

Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM, Goodman MM, Shirakami Y, Tamai I, Kawai K.

Nucl Med Biol. 2013 Jul;40(5):670-5. doi: 10.1016/j.nucmedbio.2013.03.009. Epub 2013 May 3. Erratum in: Nucl Med Biol. 2015 May;42(5):513-514. Nucl Med Biol. 2015 May;42(5):513-4.

PMID:
23647854
50.

Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.

Amzat R, Taleghani P, Miller DL, Beitler JJ, Bellamy LM, Nye JA, Yu W, Savir-Baruch B, Osunkoya AO, Chen Z, Auffermann WF, Goodman MM, Schuster DM.

Mol Imaging Biol. 2013 Oct;15(5):633-43. doi: 10.1007/s11307-012-0606-7.

PMID:
23595643

Supplemental Content

Loading ...
Support Center